ACE2 and COVID-19: ACE2 converts angiotensin II to angiotensin 1–7 (Ang 1–7), which promotes vasodilation, and enhanced ACE2 activity has been shown to mediate a protective effect in patients with COVID-19 based on anti-inflammatory benefits due to the enhancement of ACE2 [17].